Patents by Inventor Adam Linke

Adam Linke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7132245
    Abstract: The application discloses markers associated with organ transplant rejection and associated conditions, and in particular provides materials and methods for the diagnosis, prognosis or treatment of chronic rejection of transplanted organ such as heart and kidney. Examples of the markers include ribosomal protein L7, ?-transducin, 1-TRAF (also known as TANK) or lysyl-tRNA synthetase, or antibodies against these antigens.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: November 7, 2006
    Assignee: Imperial Innovation Limited
    Inventors: Marlene Lydia Rose, Michael John Dunn, Adam Linke
  • Publication number: 20050277157
    Abstract: The application discloses markers associated with organ transplant rejection and associated conditions, and in particular provides materials and methods for the diagnosis, prognosis or treatment of chronic rejection of transplanted organ such as heart and kidney. Examples of the markers include ribosomal protein L7, ?-transducin, 1-TRAF (also known as TANK) or lysyl-tRNA synthetase, or antibodies against these antigens.
    Type: Application
    Filed: November 29, 2000
    Publication date: December 15, 2005
    Inventors: Marlene Rose, Michael Dunn, Adam Linke